33
Participants
Start Date
November 30, 2008
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Donepezil
Study participants will be treated with donepezil orally at an initial dose of 5 mg daily for the first 4 weeks, then increased at their 30-day visit by 5 mg to a maximum dose of 10 mg daily, if tolerated. If the participant does not tolerate the 10 mg dose, they will remain on 5 mg through the course of the study.
Mayo Clinic, Jacksonville
Lead Sponsor
Mayo Clinic
OTHER